Follow
Ali Manouchehrinia
Ali Manouchehrinia
Dr.
Verified email at ki.se - Homepage
Title
Cited by
Cited by
Year
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ...
The Lancet Neurology 21 (3), 246-257, 2022
2522022
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
A Manouchehrinia, CR Tench, J Maxted, RH Bibani, J Britton, ...
Brain 136 (7), 2298-2304, 2013
2182013
Effect of smoking cessation on multiple sclerosis prognosis
R Ramanujam, AK Hedström, A Manouchehrinia, L Alfredsson, T Olsson, ...
JAMA neurology 72 (10), 1117-1123, 2015
1992015
Importance of early treatment initiation in the clinical course of multiple sclerosis
A Kavaliunas, A Manouchehrinia, L Stawiarz, R Ramanujam, J Agholme, ...
Multiple Sclerosis Journal 23 (9), 1233-1240, 2017
1742017
Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
A Manouchehrinia, F Piehl, J Hillert, J Kuhle, L Alfredsson, T Olsson, ...
Annals of clinical and translational neurology 7 (1), 139-143, 2020
1432020
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
A Manouchehrinia, R Tanasescu, CR Tench, CS Constantinescu
Journal of Neurology, Neurosurgery & Psychiatry 87 (3), 324-331, 2016
1332016
Age related multiple sclerosis severity score: disability ranked by age
A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ...
Multiple Sclerosis Journal 23 (14), 1938-1946, 2017
1322017
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
B Delcoigne, A Manouchehrinia, C Barro, P Benkert, Z Michalak, ...
Neurology 94 (11), e1201-e1212, 2020
1142020
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ...
Brain 140 (9), 2426-2443, 2017
1142017
Rituximab in multiple sclerosis: frequency and clinical relevance of anti-drug antibodies
N Dunn, A Juto, M Ryner, A Manouchehrinia, L Piccoli, K Fink, F Piehl, ...
Multiple Sclerosis Journal 24 (9), 1224-1233, 2018
1002018
Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis
KA McKay, A Manouchehrinia, L Berrigan, JD Fisk, T Olsson, J Hillert
JAMA neurology 76 (9), 1028-1034, 2019
902019
Long-term disability progression of pediatric-onset multiple sclerosis
KA McKay, J Hillert, A Manouchehrinia
Neurology 92 (24), e2764-e2773, 2019
882019
Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
S Binzer, KA McKay, P Brenner, J Hillert, A Manouchehrinia
Neurology 93 (24), e2216-e2223, 2019
842019
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
A Manouchehrinia, P Stridh, M Khademi, D Leppert, C Barro, Z Michalak, ...
Neurology 94 (23), e2457-e2467, 2020
712020
Predicting risk of secondary progression in multiple sclerosis: a nomogram
A Manouchehrinia, F Zhu, D Piani-Meier, M Lange, DG Silva, ...
Multiple Sclerosis Journal 25 (8), 1102-1112, 2019
702019
Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: a nationwide population-based cohort study in Sweden
O Beiki, P Frumento, M Bottai, A Manouchehrinia, J Hillert
JAMA neurology 76 (6), 665-671, 2019
672019
Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis
M Alrouji, A Manouchehrinia, B Gran, CS Constantinescu
Journal of neuroimmunology 329, 24-34, 2019
672019
Clinical course of multiple sclerosis: a nationwide cohort study
A Manouchehrinia, O Beiki, J Hillert
Multiple Sclerosis Journal 23 (11), 1488-1495, 2017
652017
Smoking and worsening disability in multiple sclerosis: A meta‐analysis
P Heydarpour, A Manouchehrinia, O Beiki, SE Mousavi, A Abdolalizadeh, ...
Acta Neurologica Scandinavica 138 (1), 62-69, 2018
592018
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
A Kavaliunas, V Danylaite Karrenbauer, H Gyllensten, A Manouchehrinia, ...
Multiple Sclerosis Journal 25 (1), 104-112, 2019
532019
The system can't perform the operation now. Try again later.
Articles 1–20